Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 3, 2013, Pages 709-715

  Ebright, Michael I ^a   Russo, Gregory A ^a   Gupta, Avneesh ^a   Subramaniam, Rathan M ^a   Fernando, Hiran C ^a   Kachnic, Lisa A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84873995084     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.12.024     Document Type: Conference Paper

References (24)

1. T. Inoue, S. Shimizu, R. Onimaru, A. Takeda, H. Onishi, and Y. Nagata Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687
2. A.J. Fakiris, R.C. McGarry, C.T. Yiannoutsos, L. Papiez, M. Williams, and M.A. Henderson Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
3. R.C. McGarry, L. Papiez, M. Williams, T. Whitford, and R.D. Timmerman Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015
4. R. Timmerman, R. McGarry, C. Yiannoutsos, L. Papiez, K. Tudor, and J. DeLuca Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
5. L.C. Fang, R. Komaki, P. Allen, T. Guerrero, R. Mohan, and J.D. Cox Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy Int J Radiat Oncol Biol Phys 66 2006 108 116
6. L. Potters, B. Kavanagh, J.M. Galvin, J.M. Hevezi, N.A. Janjan, and D.A. Larson American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 76 2010 326 332
7. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
8. D.J. Hoopes, M. Tann, J.W. Fletcher, J.A. Forquer, P.F. Lin, and S.S. Lo FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
9. M.A. Henderson, D.J. Hoopes, J.W. Fletcher, P.F. Lin, M. Tann, and C.T. Yiannoutsos A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 76 2010 789 795
10. J. van Loon, J. Grutters, R. Wanders, L. Boersma, M. Oellers, and A.M. Dingemans Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study Eur J Cancer 45 2009 588 595
11. J.A. Verschakelen, W. De Wever, and J. Bogaert Role of computed tomography in lung cancer staging Curr Opin Pulm Med 10 2004 248 255
12. L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer Oncologist 9 2004 633 643
13. D.J. Raz, J.A. Zell, S.H. Ou, D.R. Gandara, H. Anton-Culver, and D.M. Jablons Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199
14. X. Zhang, H. Liu, P. Balter, P.K. Allen, R. Komaki, and T. Pan Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 1558 1565
15. G.E. Darling, D.E. Maziak, R.I. Inculet, K.Y. Gulenchyn, A.A. Driedger, and Y.C. Ung Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial J Thorac Oncol 6 2011 1367 1372
16. C.R. Kelsey, R.W. Clough, and L.B. Marks Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy Cancer J 12 2006 283 288
17. X.W. Cai, L.Y. Xu, L. Wang, J.A. Hayman, A.C. Chang, and A. Pickens Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 76 2010 1100 1105
18. J.E. Bauman, M.S. Mulligan, R.G. Martins, B.F. Kurland, K.D. Eaton, and D.E. Wood Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes Ann Thorac Surg 86 2008 1632 1638 discussion 1638-9
19. F. Chen, Y. Matsuo, A. Yoshizawa, T. Sato, H. Sakai, and T. Bando Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients J Thorac Oncol 5 2010 1999 2002
20. T. Tada, H. Fukuda, K. Matsui, T. Hirashima, M. Hosono, and Y. Takada Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy Int J Clin Oncol 10 2005 247 250
21. Y. Manabe, Y. Shibamoto, F. Baba, H. Murata, S. Ogino, and S. Ayakawa Definitive radiotherapy for hilar or mediastinal lymph node metastases after stereotactic body radiotherapy for stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 78 3S 2010 S181
22. D. Sarwate, S. Sarkar, W.S. Krimsky, C.M. Burgan, K. Patel, and R. Evans Optimization of mediastinal staging in potential candidates for stereotactic radiosurgery of the chest J Thorac Cardiovasc Surg 144 2012 81 86
23. A. Ketchedjian, B.D. Daly, H.C. Fernando, L. Florin, C.J. Hunter, and D.M. Morelli Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma J Thorac Cardiovasc Surg 132 2006 544 548
24. E.E. Wilcox, G.M. Daskalov, H. Lincoln, R.C. Shumway, B.M. Kaplan, and J.M. Colasanto Comparison of planned dose distributions calculated by Monte Carlo and Ray-Trace algorithms for the treatment of lung tumors with cyberknife: a preliminary study in 33 patients Int J Radiat Oncol Biol Phys 77 2010 277 284